RECOURSE Study Finds TAS-102 Effective in Colorectal CancerByAtsushi Ohtsu, MD, PhDJune 7th 2015In this video, Dr. Atsushi Ohtsu discusses the use of TAS-102, an oral combination of trifluridine and tipiracil hydrochloride, in refractory colorectal cancer.